Kronox Lab Sciences Limited IPO

Kronox Lab Sciences Limited IPO is listed on BSE and NSE, priced at ₹129–₹136 per share. The stock debuted at ₹164.95, delivering a listing gain of 21.3%. The IPO had a lot size of ₹110 shares and a minimum investment of ₹14,960.

Kronox Lab Sciences Limited IPO

Mainboard Listed
₹14,960 (110 Shares)
Minimum Investment
Check Allotment
IPO Dates
Jun 3, 2024 – Jun 5, 2024
Price band
₹129-136 per equity share
Minimum Investment
₹14,960
Issue size
₹130.15 Cr
Lot size
110
Allotment Date
Jun 6, 2024
Listing
Jun 10, 2024
Listing At
BSE, NSE

IPO timeline

  1. Jun 3, 2024

    Open Date

    Completed

  2. Jun 5, 2024

    Close Date

    Completed

  3. Jun 6, 2024

    Allotment Date

    Completed

  4. Jun 10, 2024

    Listing Date

    Completed

Price Summary

Last closing
133.07 (-2.15%)
52 week high
207.49
52 week low
96.00
Last update

Kronox Lab Sciences Limited IPO Essentials

Kronox Lab Sciences Limited IPO Details

Kronox Lab Sciences Limited IPO is priced at ₹129-136 per share with a total issue size of 130.15 crore. The IPO has a lot size of 110 shares and is listed on BSE and NSE.

Issue price
₹129-136 per equity share
Lot size
110 shares
Face value
₹10 Per Equity Share
Issue size
Offer for Sale : 9,570,000 shares(aggregating up to ₹130.15 Cr)
Total issue size
95,70,000 shares
(aggregating up to ₹130.15 crore)
Offer for sale (OFS)
95,70,000 shares
(aggregating up to ₹130.15 crore)
Listing at
BSE, NSE
List price
164.95(NSE)
Listing date
Registrar
Kfin Technologies Limited
Lead manager
Pantomath Capital Advisors Pvt Ltd

Market Lot Size

Investors can bid for a minimum of 110 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.

Application Lots Shares Amount
Retail (min) 1 110 ₹14,960
Retail(max) 13 1,430 ₹1,94,480

Kronox Lab Sciences Limited IPO Documents

Kronox Lab Sciences Limited IPO Reservation

Kronox Lab Sciences Limited IPO reservation details show category-wise allocation of shares. Out of the total 9,570,000 shares, approximately 20% are reserved for QIB, 15% for NII, 35% for retail investors, and 30% for anchor investors.

Investor Category Shares Offered Maximum Allottees
Anchor Investor Shares Offered 2,871,000 (30%)
QIB Shares Offered 1,914,000 (20%)
NII (HNI) Shares Offered 1,435,500 (15%)
bHNI > ₹10L 957,000 (10%) 621
sHNI < ₹10L 478,500 (5%) 310
Retail Shares Offered 3,349,500 (35%) 30,450
Total Shares Offered 9,570,000 (100%)

Kronox Lab Sciences Limited IPO Analytics

Kronox Lab Sciences Limited IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.

Kronox Lab Sciences Limited IPO Subscription Status

Kronox Lab Sciences Limited IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.

The IPO subscription status indicates investor demand across categories.

As on QIB
NII
bHNI
sHNI
Retail Total
Shares Offered / Reserved 4,785,000
1,435,500
957,000
478,500
3,349,500 6,699,000
Day 1 03-06-24 05:00 PM
1.11 x
19.97x
15.93x
28.05x
13.00 x 11.10 x
Day 2 04-06-24 05:00 PM
3.39 x
52.94x
45.18x
68.47x
24.55 x 24.59 x
Day 3 05-06-24 05:00 PM
89.03 x
301.92x
322.26x
261.23x
54.23 x 117.25 x
Total No. of Applications
bHNI sHNI Retail
15,28,029 (Approx) —x —x 50.1x

Kronox Lab Sciences Limited Valuations

Earnings

EPS Pre IPO
₹4.48/-
EPS Post IPO
₹5.56/-
P/E Pre IPO
30.37
P/E Post IPO
24.47

Returns

ROE
25.66%
ROCE
33.15%
RoNW
25.66%
PAT Margin
22.60

Fundamentals

Price / Book
8.37

Data sourced from DRHP / RHP • For educational purposes only

Kronox Lab Sciences Limited Financials( In Crs.)

31-Mar-23 31-Mar-22 31-Mar-21
Assets 54.03 56.79 37.65
Revenue 97.50 83.34 63.24
Profit After Tax 16.62 13.63 9.73
Net Worth 44.68 40.35 26.81
Reserves & Surplus 7.58 40.11 26.57

Kronox Lab Sciences Limited Company & Offer Insights

About Kronox Lab Sciences Limited

Kronox Lab Sciences Limited is a manufacturer of high-purity speciality fine chemicals for diverse end-user industries. The company's High Purity Specialty Fine Chemicals are used in various applications such as manufacturing APIs, pharmaceutical formulations, scientific research, nutraceuticals, biotech applications, agrochemical formulations, personal care products, metal refineries, and animal health products.

The company offers a wide range of over 185 products, including phosphate, sulphate, acetate, chloride, citrate, nitrates, nitrites, carbonate, EDTA derivatives, hydroxide, succinate, gluconate, and others. These products are supplied to customers in India and more than 20 countries worldwide.

The company exports its products to countries such as United States, Argentina, Mexico, Australia, Egypt, Spain, Turkey, United Kingdom, Belgium, United Arab Emirates, China, among others.

The company has three manufacturing facilities in Vadodara, Gujarat, close to the seaports of Mundra, Kandla, Hazira, and Nhava Sheva. The facilities cover 17,454 sq. m. and have an installed capacity of 7,242 TPA as of December 31, 2023. Unit I/II holds FSSC 22000 (Version 5), ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018 certifications. Additionally, some products manufactured at Unit I have obtained Kosher, Halal, GMP, and GLP certifications.

As of December 31, 2023, the company is conducting research and development on 122 products.

The company has served over 592 customers in the past three years. By December 31, 2023, 141 customers of the total, placed repeat orders.

As of December 31, 2023, the company employees 212 people at various levels.

Kronox Lab Sciences Limited Promoter(s)

Jogindersingh Jaswal, Ketan Ramani, Pritesh Ramani are the company's promoters of Kronox Lab Sciences Limited.

Kronox Lab Sciences Limited IPO Issue Objectives

Carry out the Offer for Sale of up to 95,70,000 Equity Shares by the Promoter Selling Shareholders
Achieve the benefits of listing the Equity Shares on the Stock Exchanges. Further, the Company expects that the proposed listing of the Equity Shares will enhance the visibility and brand image, provide liquidity to its existing Shareholders, and provide a public market for Equity Shares in India.

Kronox Lab Sciences Limited IPO - Anchor Investors

Kronox Lab Sciences raises over Rs 39 crore from anchor investors ahead of IPO.

Negen Undiscovered Value Fund is the biggest institutional investor among them, buying Rs 7.57 crore worth of shares, followed by Chanakya Opportunities Fund I and Minerva Emerging Opportunities Fund, which picked up Rs 7.48 crore worth of equity shares each.

Capri Global Capital, Moneywise Financial Services, and VPK Global Ventures Fund bought Rs 5.5 crore worth of shares each.

Kronox Lab Sciences Limited IPO - Peers Comparison

Company Name EPS (Basic) EPS (Diluted) NAV (per share) (Rs) P/E (x) RoNW (%) P/BV Ratio Financial statements
Kronox Lab Sciences Limited 4.3 4.3 12.04 N/A 37.19 11.3 Consolidated
Tatva Chintan Pharma Chem Limited 19.45 19.45 220.07 57.57 8.84 5.09 Consolidated
Tanfac Industries Ltd. 56.27 56.27 184.74 39.15 30.46 11.92 Consolidated
Neogen Chemicals Ltd 18.94 18.94 182.9 77.55 10.36 8.03 Consolidated
Sigachi Industries Limited 1.42 1.42 8.73 46.64 16.22 7.57 Consolidated
DMCC Speciality Chemical Limited 2.78 2.78 79.49 116.57 3.5 4.08 Consolidated

Notes:

  1. Current Market Price (CMP) is the closing prices of respective scrips as on May 17, 2024.
  2. The P/E Ratio has been computed based on the closing market price of equity shares on May 17, 2024, divided by the diluted EPS.
  3. RoNW is computed as net profit after tax attributable to equity shareholders divided by Net Worth as at March 31, 2023.
  4. NAV is computed as the closing Net Worth divided by the closing outstanding number of equity shares.

Kronox Lab Sciences Limited IPO - Strengths and Risks

Kronox Lab Sciences Limited IPO strengths and risks highlight key business factors, financial position, and market sentiment that may impact investor interest.

Strengths

Kronox Lab Sciences Limited offers a diverse product range of over 185 High Purity Speciality Fine Chemicals, consistently selling 156 to 188 products annually, indicating product demand.
The company maintains strong customer retention, with 111 repeat clients representing 16.74% of total customers, demonstrating reliability and customer satisfaction over consecutive fiscal periods.
Extensive R&D focus led by a Chairman with over 30 years of experience, supported by 16 specialised personnel in their RDT Laboratory, underpins innovation and high-quality product development.

Risks

Kronox Lab Sciences faces risks if their products deviate from prescribed standards like IP, BP, EP, JP, USP, potentially leading to customer rejection and harming their reputation.
The company's growth strategy relies on a new manufacturing facility; failure to execute this could affect their business prospects and financial stability.
With top 20 products generating over 60% of revenue, a demand drop in these could significantly impact Kronox's financial results and cash flow stability.

Contact Information

Contact Details

Kronox Lab Sciences Limited

+91 26 6224 4077/88

cs@kronoxlabsciences.com

https://www.kronoxlabsciences.com/

Block No. 353, Village Ekalbara, Padra, Vadodara-391440

Registrar Contact Details

Kfin Technologies Limited

04067162222, 04079611000

klsl.ipo@kfintech.com

https://kosmic.kfintech.com/ipostatus/

Frequently Asked Questions

Click any question to reveal the answer

Kronox Lab Sciences Limited IPO is a book-built IPO worth ₹130.15 crore. The price band is ₹129–₹136 per share. The IPO opens on Jun 3, 2024 and closes on Jun 5, 2024. It will be listed on BSE and NSE. Kfin Technologies Limited is the registrar.

The price band of Kronox Lab Sciences Limited IPO is ₹129 to ₹136 per share.

The lot size of Kronox Lab Sciences Limited IPO is 110 shares.

The minimum investment for Kronox Lab Sciences Limited IPO is approximately ₹14,960 based on the upper price band .

Kronox Lab Sciences Limited IPO opens on Jun 3, 2024 and closes on Jun 5, 2024.

The allotment date of Kronox Lab Sciences Limited IPO is Jun 6, 2024.

Kronox Lab Sciences Limited IPO is expected to be listed on Jun 10, 2024, on BSE and NSE .

Kronox Lab Sciences Limited IPO listed on Jun 10, 2024. It was issued at ₹164.95(NSE) and is currently around ₹133.07 as on 14-May-2026 3:30 PM, which is approximately -2.2% versus issue price. The 52-week high is ₹207.49.

Based on listing and post-listing performance, Kronox Lab Sciences Limited IPO delivered around -2.2% over issue price. Whether it was worth applying depends on your risk profile, allocation, and holding horizon.

To buy Kronox Lab Sciences Limited IPO shares after listing, log in to your broker app (such as Zerodha, Angel One, Groww, Upstox, ICICI Direct), search the stock symbol, place a delivery/CNC order, and confirm quantity and price.

Kronox Lab Sciences Limited IPO valuation snapshot: P/E 24.47, EPS ₹5.56/-, P/B 8.37, RoNW 25.66%, and market cap N/A.

To apply for Kronox Lab Sciences Limited IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.

You can check the live subscription status of Kronox Lab Sciences Limited IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.

Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.

If you pre-apply for Kronox Lab Sciences Limited IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.

You can check Kronox Lab Sciences Limited IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Kronox Lab Sciences Limited IPO allotment status on IPO Ji for quick and easy access.